Treatment of Chronic Subdural Hematoma by Corticosteroids — SUCRE

Chronic Subdural Hematomas Clinical Trial

Official title:
Treatment of Chronic Subdural Hematoma by Corticosteroids

Status Completed

Clinical Trial Summary

Chronic subdural hematomas are a frequent neurosurgical pathology in the elderly. Gold standard is surgical evacuation of these hematomas. Physiopathology of chronic subdural hematoma involves numerous inflammatory processes which could be inhibited by steroids.

Clinical Trial Description

The primary objective is to evaluate the efficacy of corticosteroids treatment in patients with Chronic subdural hematomas without clinical or radiological signs of severity.

Secondary objectives are to assess the effect of methylprednisolone on:

- quality of life evolution,

- morbidity and mortality,

- radiological evolution of the lesions. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02650609
Study type	Interventional
Source	Rennes University Hospital
Contact
Status	Completed
Phase	Phase 3
Start date	June 24, 2016
Completion date	March 20, 2020

View Details

See also
	Status	Clinical Trial	Phase
	Not yet recruiting	`NCT06163547` - Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM)	N/A
	Recruiting	`NCT04511572` - Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma	N/A